Showing results (1431-1440 of 1,809) with videos related to
Sort By:
Pageof 181
Journal of Surgical Oncology|July 11, 2024
Evaluating surgeon communication of pancreatic cancer prognosis using the VitalTalk ADAPT frameworkLindsay K Dickerson, Trisha A Lipson, Sardar Shahmir B Chauhan, et al.Psychopharmacology|March 13, 2010
Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activationChad E Beyer, Jason M Dwyer, Brian J Platt, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2017
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point 18F-FDG PET/CT Imaging in Patients with Advanced MelanomaSteve Y Cho, Evan J Lipson, Hyung-Jun Im, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 29, 2005
Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipientVivek N Ahya, Alden M Doyle, James D Mendez, et al.Cancer Discovery|March 28, 2013
Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomasAlexander Drilon, Lu Wang, Adnan Hasanovic, et al.COPD|September 29, 2018
The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial)Jinping Zheng, Nanshan Zhong, Changzheng Wang, et al.The American Journal of Managed Care|December 27, 2018
Adalimumab persistence for inflammatory bowel disease in veteran and insured cohortsShail M Govani, Rachel Lipson, Mohamed Noureldin, et al.Inflammatory Bowel Diseases|December 23, 2017
Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine LearningAkbar K Waljee, Rachel Lipson, Wyndy L Wiitala, et al.The Journal of Pharmacology and Experimental Therapeutics|February 12, 2005
WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activityJohn Dunlop, Annmarie L Sabb, Hossein Mazandarani, et al.Nature|July 31, 2010
New class of gene-termini-associated human RNAs suggests a novel RNA copying mechanismPhilipp Kapranov, Fatih Ozsolak, Sang Woo Kim, et al.Pageof 181